enVVeno Medical Corporation (NVNO) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

enVVeno Medical Corporation (NVNO) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $5.5M, listed on NASDAQ, employing roughly 33 people, carrying a beta of 1.07 to the broader market. enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. Led by Robert A. Berman, public since 2018-05-31.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for NVNO as of 2026-10-15; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →